Pellucid marginal degeneration
|Pellucid marginal degeneration|
|Classification and external resources|
Pellucid marginal degeneration (PMD; keratotorus), is a degenerative corneal condition, often confused with keratoconus. It is typically characterized by a clear, bilateral thinning (ectasia) in the inferior and peripheral region of the cornea, although some cases affect only one eye. The cause of the disease remains unclear (idiopathic).
The term "pellucid marginal degeneration" was first coined in 1957 by the ophthalmologist Schalaeppi. The word "pellucid" means clear, indicating that the corneas retain clarity in pellucid marginal degeneration.
Signs and Symptoms
Unlike keratoconus, pain is not typically present in pellucid marginal degeneration, and aside from vision loss, no symptoms accompany the condition. However, in rare cases, PMD may present with sudden onset vision loss and excruciating eye pain, which occurs if the thinning of the cornea leads to perforation. While PMD usually affects both eyes, some unilateral cases have been reported.
PMD is characterized by bilateral thinning (ectasia) in the inferior and peripheral region of the cornea. The distribution of the degeneration is crescent or arcuate shaped. The cornea just above the region of thinning is of normal thickness, and may protrude anteriorly, which creates an irregular astigmatism. This is described as a "beer belly" appearance since the greatest protrusion occurs below the horizontal midline (unlike keratoconus). Normally, PMD does not present with vascularization of the cornea, scarring, or any deposits of lipid.
PMD is an idiopathic, non-inflammatory condition. The thinning of the corneas may approach 20% of normal thickness. There may be an increase in the number of mucopolysaccharides in the corneal stroma. The Bowman's layer of the cornea may be absent, irregular, or have ruptured areas.
The center of the cornea shows normal thickness, with an intact central epithelium, but the inferior cornea exhibits a peripheral band of thinning, to about 1–2 mm. The portion of the cornea that is immediately adjacent to the limbus is spared, usually a strip of about 1–2 mm. In PMD we can see high against the rule astigmatism along with horizontal bow ties. The inferior peripheral thinning is seen between the 4 o'clock and 8 o'clock positions.
The gold standard diagnostic test for PMD is corneal topography. However, it may not as specific as corneal pachymetry, because corneal topography only evaluates the degree and distribution of surface irregularities on the cornea, not the thickness of the cornea. Corneal topography may show a "crab claw-like" appearance, a finding that is seen in both keratoconus and in pellucid marginal degeneration. Thus, if corneal topography is used for diagnosis, it should be in conjunction with clinical findings of peripheral, inferior corneal thinning.
Most patients can be treated non-surgically with eyeglasses, or contact lenses.
The early stages of pellucid marginal degeneration may also be managed with soft contact lenses. Success has been shown with the use of rigid contact lenses combined with over-refraction. Patients wearing contacts report increased problems with glare and contrast sensitivity, but it is not clear if this is due to the corneal disease, or the contact lenses themselves.
New studies found that the use of Scleral contact lens, also known as a gas permeable ("GP") lens, may be a good option for most patients with PMD. Most of these lenses are in the range of 15.5mm to 18.0mm in diameter. Regardless of the lens size, it is thought that the larger the GP lens, regardless of the fact that it is a rigid lens, will in most cases be more comfortable then standard rigid corneal lenses, and at times more comfortable than soft lenses. The highlight to the scleral design and the correction of eye disorders such as pellucid marginal degeneration is that vision with these types of lenses is exceptional when fit correctly.
There is evidence suggesting corneal collagen cross-linking may be beneficial for patients with pellucid marginal degeneration. Research shows some promising results by combining collagen cross linking with photorefractive keratectomy, or with topography-guided transepithelial surface ablation.
Corneal transplant surgery may be difficult due to the peripheral thinning of the cornea, even with large and off-center grafts. Therefore, surgery is usually reserved for patients that do not tolerate contact lenses. Several different surgical approaches may be taken, and no one approach is currently established as the standard. Examples of surgical procedures used for PMD include: wedge resection, lamellar crescentic resection, penetrating keratoplasty, lamellar keratoplasty, epikeratoplasty and intracorneal segments. Transplantation of the entire thickness of the cornea (penetrating keratoplasty) may be performed if there is enough normal tissue present. However, if there is not enough normal tissue present, then attaching the graft is difficult.
The incidence and prevalence of PMD are unknown, and no studies have yet investigated its prevalence or incidence. However, it is generally agreed that PMD is a very rare condition. Some uncertainty regarding the incidence of PMD may be attributed to its confusion with keratoconus. PMD is not linked to race or age, although most cases present early in life, between 20 and 40 years of age. While PMD is usually considered to affect men and women equally, some studies suggest that it may affect men more frequently.
Several diseases have been observed in patients with PMD. However, no causal relationships have been established between the any of the associated diseases and the pathogenesis of PMD. Such diseases include: chronic open-angle glaucoma, retinitis pigmentosa, retinal lattice degeneration, scleroderma, kerato-conjunctivitis, eczema, and hyperthyroidism.
Visual function declines as a result of the irregular corneal shape, resulting in astigmatism, and causing a distortion in vision. Deterioration can become severe over time.
- Karim Rasheed, MD (2005). "Pellucid Marginal Degeneration". WebMD. Retrieved September 3, 2007.
- Jinabhai, Amit; Radhakrishnan, Hema; o’Donnell, Clare (2011). "Pellucid corneal marginal degeneration: A review". Contact Lens and Anterior Eye 34 (2): 56–63. doi:10.1016/j.clae.2010.11.007. PMID 21185225.
- Basak, SK; Hazra, TK; Bhattacharya, D; Sinha, TK (2000). "Unilateral pellucid marginal degeneration". Indian journal of ophthalmology 48 (3): 233–4. PMID 11217258.
- Kaushik, S; Jain, A K; Saini, J S (2003). "Unilateral pellucid marginal degeneration". Eye 17 (2): 246–8. doi:10.1038/sj.eye.6700301. PMID 12640416.
- Belin, Michael W.; Asota, Ijeoma M.; Ambrosio, Renato; Khachikian, Stephen S. (2011). "What's in a Name: Keratoconus, Pellucid Marginal Degeneration, and Related Thinning Disorders". American Journal of Ophthalmology 152 (2): 157–162.e1. doi:10.1016/j.ajo.2011.03.028. PMID 21708379.
- Krachmer, JH (1978). "Pellucid marginal corneal degeneration". Archives of ophthalmology 96 (7): 1217–21. doi:10.1001/archopht.1978.03910060051009. PMID 352310.
- Hovakimyan, Marine; Guthoff, Rudolf F.; Stachs, Oliver (31 March 2011). "Collagen Cross-Linking: Current Status and Future Directions". Journal of Ophthalmology 2012: 1–12. doi:10.1155/2012/406850. Retrieved 11 November 2012.
- Lee, Brandon W.; Jurkunas, Ula V.; Harissi-Dagher, Mona; Poothullil, Antony M.; Tobaigy, Faisal M.; Azar, Dimitri T. (2007). "Ectatic Disorders Associated with a Claw-shaped Pattern on Corneal Topography". American Journal of Ophthalmology 144 (1): 154–156. doi:10.1016/j.ajo.2007.02.032. PMID 17601448.
- Tzelikis, PF; Cohen, EJ; Rapuano, CJ; Hammersmith, KM; Laibson, PR (2005). "Management of pellucid marginal corneal degeneration". Cornea 24 (5): 555–60. doi:10.1097/01.ico.0000153555.82278.5b. PMID 15968160.
- Kymionis, George D; Aslanides, Ioannis M; Siganos, Charalambos S; Pallikaris, Ioannis G (2004). "Intacs for early pellucid marginal degeneration". Journal of Cataract & Refractive Surgery 30: 230. doi:10.1016/S0886-3350(03)00656-4.
- Intacs (2005). "A new FDA approved option for keratoconus filling the gap between contact lenses and a corneal transplant". Intacs. Archived from the original on August 9, 2007. Retrieved September 3, 2007.
- Kozobolis, Vassilios; Labiris, G; Gkika, M; Sideroudi, H (2011). "Additional Applications of Corneal Cross Linking". The Open Ophthalmology Journal 5: 17–8. doi:10.2174/1874364101105010017. PMC 3065117. PMID 21448300.
- Kymionis, George D.; Karavitaki, Alexandra E.; Kounis, George A.; Portaliou, Dimitra M.; Yoo, Sonia H.; Pallikaris, Ioannis G. (2009). "Management of pellucid marginal corneal degeneration with simultaneous customized photorefractive keratectomy and collagen crosslinking". Journal of Cataract & Refractive Surgery 35 (7): 1298–301. doi:10.1016/j.jcrs.2009.03.025. PMID 19545822.
- Spadea, Leopoldo (2010). "Corneal Collagen Cross-Linking with Riboflavin and UVA Irradiation in Pellucid Marginal Degeneration". Journal of Refractive Surgery 26 (5): 375–7. doi:10.3928/1081597X-20100114-03. PMID 20128533.
- Ophthalmology Times (2006). "Signs of pellucid marginal degeneration should rule out refractive surgery". Ophthalmology Times. Retrieved September 3, 2007.
- Sii, F; Lee, GA; Sanfilippo, P; Stephensen, DC (2004). "Pellucid marginal degeneration and scleroderma". Clinical & experimental optometry 87 (3): 180–4. doi:10.1111/j.1444-0938.2004.tb03172.x. PMID 15186210.
- Keratotorus (Pellucid Marginal Degeneration) - Atlas of ophthalmology